NCT02276391View on ClinicalTrials.gov

Bioequivalence of Telmisartan as Telmisartan 80 mg/HCTZ 12.5 mg Fixed-dose Combination Tablet or as Two Telmisartan 40 mg Tablets in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

October 31, 2008

Conditions
Healthy
Interventions
DRUG

Telmisartan/HCTZ combination

DRUG

Telmisartan

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY